- Home
- DIN vs TSHA Comparison
DIN vs TSHA Comparison
Compare DIN & TSHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DIN
- TSHA
- Stock Information
- Founded
- DIN 1958
- TSHA 2019
- Country
- DIN United States
- TSHA United States
- Employees
- DIN N/A
- TSHA N/A
- Industry
- DIN Restaurants
- TSHA Biotechnology: Pharmaceutical Preparations
- Sector
- DIN Consumer Discretionary
- TSHA Health Care
- Exchange
- DIN Nasdaq
- TSHA Nasdaq
- Market Cap
- DIN 379.1M
- TSHA 397.8M
- IPO Year
- DIN 1991
- TSHA 2020
- Fundamental
- Price
- DIN $23.61
- TSHA $2.78
- Analyst Decision
- DIN Hold
- TSHA Strong Buy
- Analyst Count
- DIN 8
- TSHA 7
- Target Price
- DIN $26.33
- TSHA $7.57
- AVG Volume (30 Days)
- DIN 493.5K
- TSHA 5.1M
- Earning Date
- DIN 05-07-2025
- TSHA 05-15-2025
- Dividend Yield
- DIN 8.65%
- TSHA N/A
- EPS Growth
- DIN N/A
- TSHA N/A
- EPS
- DIN 3.61
- TSHA N/A
- Revenue
- DIN $820,851,000.00
- TSHA $7,224,000.00
- Revenue This Year
- DIN $8.51
- TSHA N/A
- Revenue Next Year
- DIN $1.99
- TSHA N/A
- P/E Ratio
- DIN $6.53
- TSHA N/A
- Revenue Growth
- DIN N/A
- TSHA N/A
- 52 Week Low
- DIN $18.63
- TSHA $1.05
- 52 Week High
- DIN $40.75
- TSHA $4.32
- Technical
- Relative Strength Index (RSI)
- DIN 53.59
- TSHA 61.93
- Support Level
- DIN $23.30
- TSHA $2.66
- Resistance Level
- DIN $25.03
- TSHA $2.95
- Average True Range (ATR)
- DIN 0.83
- TSHA 0.25
- MACD
- DIN -0.03
- TSHA -0.02
- Stochastic Oscillator
- DIN 56.84
- TSHA 52.58
About DIN Dine Brands Global Inc.
Dine Brands Global Inc owns and franchises thousands of restaurants under the Applebee's and International House of Pancakes names. Almost all company restaurants are located in the United States and franchised. Royalty revenue, which the company gets from franchisees based on franchisees' sales, accounts for roughly three-quarters of total company revenue. The company also earns revenue by leasing restaurant sites to franchisees. The company has four reportable segments Franchise operations, (an aggregation of Applebee's and IHOP franchise operations), Rental operations, Financing operations and Company-operated restaurant operations. The majority of revenue is derived from the Franchise operations segment.
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.